Catalyst Wire Dossier Catalyst Wire Dossier

BI 34021 FU2

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 34021 FU2, covering 2014-10-09 to 2014-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers [Phase 1]

See pricing